Vendor, Overland Park, KS, part of Cardinal Health, Inc.
Cardinal Health 127 Inc.
UEI JE8BA2YTP569, CAGE 6HAG3
1 award and -$22,000 obligated between July 3, 2024 and July 3, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$22,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40121C00134Definitive Contract, July 3, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | EO14042 Validation of a Novel Methodology for Endpoints Assessing Response to Lymphoma Treatment in Real-World StudiesNAICS 541990, PSC AN41 | -$22,000 |
- Places of performance
- Ohio
- Product and service codes
- AN41 Health R&D Services; Health Care - Other; Basic Research
- Transactions
- 1 across 1 awards